These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 1987769)
21. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies. Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572 [TBL] [Abstract][Full Text] [Related]
22. The distinction of Hodgkin's disease from B cell lymphoma. Warnke RA Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850 [TBL] [Abstract][Full Text] [Related]
23. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266 [TBL] [Abstract][Full Text] [Related]
24. Differential diagnosis of L26-positive, CD15-negative Hodgkin's disease and large B-cell lymphoma with a high content of reactive T-cells: a morphologic and immunohistochemical study. Nguyen DT; Diamond LW; Hansmann ML; Fischer R Hematopathol Mol Hematol; 1996; 10(3):135-50. PubMed ID: 8878732 [TBL] [Abstract][Full Text] [Related]
26. [Hodgkin disease with nodular lymphocytic predominance or type I (paragranuloma of Poppema-Lennert): a clinico-pathological entity. Study of 21 cases and review of the literature]. Meignin V; Briere J; Brice P; Gisselbrecht C; Gaulard P; Janin A Ann Pathol; 2000 Jan; 20(1):19-24. PubMed ID: 10648984 [TBL] [Abstract][Full Text] [Related]
27. Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: application of tissue microarrays. Hedvat CV; Jaffe ES; Qin J; Filippa DA; Cordon-Cardo C; Tosato G; Nimer SD; Teruya-Feldstein J Mod Pathol; 2001 Dec; 14(12):1270-6. PubMed ID: 11743050 [TBL] [Abstract][Full Text] [Related]
28. [Hodgkin's disease: a mystery is being solved]. Stein H; Hummel M; Marafioti T; Korbjuhn P; Anagnostopoulos I; Foss HD Verh Dtsch Ges Pathol; 1997; 81():327-38. PubMed ID: 9474887 [TBL] [Abstract][Full Text] [Related]
29. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma. Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176 [TBL] [Abstract][Full Text] [Related]
30. Lymphocyte predominance Hodgkin's disease: a reappraisal based upon histological and immunophenotypical findings in relapsing cases. Regula DP; Weiss LM; Warnke RA; Dorfman RF Histopathology; 1987 Nov; 11(11):1107-20. PubMed ID: 3692445 [TBL] [Abstract][Full Text] [Related]
31. The patterns of IL2, IFN-gamma, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar. Serrano D; Ghiotto F; Roncella S; Airoldi I; Cutrona G; Truini M; Burgio VL; Baroni CD; Ferrarini M; Pistoia V Haematologica; 1997; 82(5):542-9. PubMed ID: 9407718 [TBL] [Abstract][Full Text] [Related]
32. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. Regula DP; Hoppe RT; Weiss LM N Engl J Med; 1988 Jan; 318(4):214-9. PubMed ID: 3336412 [TBL] [Abstract][Full Text] [Related]
33. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas. Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334 [TBL] [Abstract][Full Text] [Related]
36. The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease. Poppema S Am J Pathol; 1989 Aug; 135(2):351-7. PubMed ID: 2675617 [TBL] [Abstract][Full Text] [Related]
37. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas. Dorfman DM; Shahsafaei A Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831 [TBL] [Abstract][Full Text] [Related]